Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuropathic pain
Pharma
Topical treatment for chemotherapy pain clears early test
With the phase 1 trial meeting its objectives, AlgoTherapeutix is now gearing up for a pivotal study in chemotherapy-induced peripheral neuropathy.
Nick Paul Taylor
Nov 22, 2021 11:55am
Lundbeck aims to grow Vyepti in busy migraine prevention field
Mar 31, 2020 10:10am
Allergan's Botox still a migraine favorite despite CGRP push
Feb 21, 2020 10:05am